2018

Rosario Fernandez-Godino receives BrightFocus Foundation Award HSCI Affiliate Faculty member Rosario Fernandez-Godino, Ph.D., M.Sc., has been selected to receive the BrightFocus Foundation Award. The award is presented by the foundation’s Macular...

The Harvard Stem Cell Institute (HSCI) was pleased to host Hideyuki Okano, M.D., Ph.D. on his tour of the Boston biomedical ecosystem in September 2018. Okano, a physiology professor and former dean at the Keio University School of Medicine in Japan, is a...

HSCI scientists identify a potential target for treating neuropathic pain Why do people with neuropathic pain feel pain from minor touches and other normally harmless stimuli? Setting out to answer this question, Harvard Stem Cell Institute (HSCI)...

HSCI scientists identify gene involved in the language regions of the brain By Jessica Lau Scientists at Boston Children’s Hospital (BCH) and the Harvard Stem Cell Institute (HSCI) have discovered a gene involved in brain development, specifically in the...

Researchers find a new type of lung cell involved in cystic fibrosis By Jessica Lau In cystic fibrosis, mucus builds up in the lungs and leads to breathing difficulties because cells do not properly make the CFTR protein. Although scientists have known...

HSCI bioengineer and cardiologist collaborate to design a radically improved model of the heart By Jessica Lau Researchers use heart cells in the laboratory to study heart disease and test potential new therapies. Many of the heart disease models they use...

Engineered cancer cells can deliver therapeutic molecules to tumors in mice By Jessica Lau Cancer cells have a self-homing ability: they can move around the body to locate tumors. This usually helps the cancer to spread, but Harvard Stem Cell Institute...

Therapeutic has applications in treating liver cancers and leukemias By Jessica Lau Summary Scientists have engineered a therapeutic molecule that blocks SALL4, a protein involved in about one-third of cancers, in mice. This therapeutic approach could be...

Douglas Melton assumed his role as president of the International Society for Stem Cell Research (ISSCR) at the closing plenary of the society’s 2018 annual meeting. He steps into this role after two years on the executive committee and will serve in this...

Advances in engineering blood cells, treating diabetes, regenerating joints, and growing organs On May 31, 2018, Harvard Stem Cell Institute (HSCI) faculty members shared their research updates at the Harvard Medical School (HMS) Alumni Reunion symposium...